Michael Landsittel
2016
In 2016, Michael Landsittel earned a total compensation of $440.9K as Vice President, Finance at Blueprint Medicines, a 49% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $80,915 |
|---|---|
| Option Awards | $100,546 |
| Salary | $251,865 |
| Other | $7,543 |
| Total | $440,869 |
Landsittel received $251.9K in salary, accounting for 57% of the total pay in 2016.
Landsittel also received $80.9K in non-equity incentive plan, $100.5K in option awards and $7.5K in other compensation.
Rankings
In 2016, Michael Landsittel's compensation ranked 11,613th out of 14,075 executives tracked by ExecPay. In other words, Landsittel earned more than 17.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,613 out of 14,075 | 18th |
Division Manufacturing | 4,532 out of 5,489 | 17th |
Major group Chemicals And Allied Products | 1,616 out of 1,895 | 15th |
Industry group Drugs | 1,307 out of 1,538 | 15th |
Industry Pharmaceutical Preparations | 1,015 out of 1,176 | 14th |
Source: SEC filing on April 27, 2018.
Landsittel's colleagues
We found five more compensation records of executives who worked with Michael Landsittel at Blueprint Medicines in 2016.
2016
Marion Dorsch
Blueprint Medicines
Chief Scientific Officer
2016
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
2016
Tracey McCain
Blueprint Medicines
Chief Legal Officer
2016
Kate Haviland
Blueprint Medicines
Chief Business Officer
2016
Anthony Boral
Blueprint Medicines